¿HAS OLVIDADO TU CONTRASEÑA?

Para enviarte una nueva contraseña, escribe la dirección de correo electrónico completa que registraste en el Directorio.

Regresar

REGISTRO

Estimado usuario(a):

El presente módulo está dirigido exclusivamente a nuevos usuarios que desean pertenecer al Directorio Nacional d e Investigadores, Tecnología e Innovación Tecnológica de CONCYTEC.

Ficha CTI Vitae
CHAVEZ FUMAGALLI MIGUEL ANGEL

Soy graduado en Medicina Veterinaria por la Universidad Federal Rural de Pernambuco (Brasil), realice la Maestría y el Doctorado en el curso de Posgrado en Farmacología Bioquímica y Molecular en la Universidad Federal de Minas Gerais (Brasil). Luego, actué como investigador posdoctoral en el Instituto em Ciencia e Tecnologia em Nanobiofarmaceutica (Brasil), en el Centro de Biología Molecular Severo Ochoa de la Universidad Autónoma de Madrid (España) y en el programa de Posgrado en Ciencias de la Salud: Enfermedades Infecciosas y Medicina Tropical, de la Facultad de Medicina de la UFMG (Brasil). Retorne al Perú como Investigador Asociado a la Universidad Católica de Santa María (UCSM) con el concurso de Incorporación de Investigadores desarrollado por CONCYTEC y el Banco Mundial. Tengo experiencia en el Diseño de Fármacos Asistido por Computadora y en Bioinformática aplicada al desarrollo de vacunas y pruebas de diagnóstico, teniendo como interés principal las enfermedades desatendidas como la Leishmaniasis y la Enfermedad de Chagas. Como Investigador Principal del Grupo de Investigación en Biología y Química Computacional de la UCSM vengo promoviendo la iniciativa de la Base de Datos de Productos Naturales del Perú (PeruNPDB) (http://perunpdb.com.pe/), que fue concebida como una herramienta para el cribado virtual e identificación de compuestos prometedores. Soy coautor de más de 120 artículos en revistas indexadas internacionales y 05 patentes (entre presentadas y concedidas), además de actuar como revisor en diversas revistas científicas de alto impacto como The Lancet Microbe (ISSN: 2666-5247) y The Lancet Infectious Diseases (ISSN: 1473-3099). Actualmente, mis índice H e i (índice i10) son de 32 y 77 (Google Scholar), respectivamente.

Fecha de última actualización: 09-11-2023
 
Código de Registro:   P0019490
Ver:   Ficha Renacyt


Scopus Author Identifier: 35271437900
Web of Science ResearcherID: AAI-9413-2020
Fecha:  04/07/2019

Datos Personales

    Fuente
Apellidos : CHAVEZ FUMAGALLI
Nombres: MIGUEL ANGEL
Género: MASCULINO
Nacionalidad: PERÚ

Datos Actuales

Pagina web personal: https://www.researchgate.net/profile/Miguel_Chavez_Fumagalli
Pais de residencia: Perú

Experiencia Laboral

Institución Cargo Descripción del cargo Cargo en I+d+i Fecha Inicio Fecha Fin
UNIVERSIDAD CATÓLICA DE SANTA MARIA DOCENTE INVESTIGADOR Otros cargos relacionados a (I+D+i) Enero 2022 A la actualidad
UNIVERSIDAD CATOLICA DE SANTA MARIA INVESTIGADOR ASOCIADO Investigador Asociado en ele proyecto "Diseño y elaboración de una prueba de diagnóstico basada en nuevos biomarcadores para la detección y monitoreo de la enfermedad de Alzheimer" financiado pelo CONCYTEC/Banco Mundial Otros cargos relacionados a (I+D+i) Noviembre 2019 Diciembre 2021
UNIVERSIDADE FEDERAL DE MINAS GERAIS INVESTIGADOR Investigador Pos doctoral con dedicación exclusiva Enero 2014 Noviembre 2019

Experiencia Laboral como Docente

Institución Tipo Institución Tipo Docente Descripción del cargo Fecha Inicio Fecha Fin
UNIVERSIDADE FEDERAL DE MINAS GERAIS Universidad Ordinario-Auxiliar Docencia libre. Parte de las actividades de residente Postdoctoral. Marzo 2017 Noviembre 2019

Experiencia como Asesor de Tesis

Universidad Tesis Tesista(s) Repositorio Fecha Aceptación de Tesis
UNIVERSIDADE FEDERAL DE MINAS GERAIS Magister Lourena Emanuele Costa Febrero 2013
UNIVERSIDADE FEDERAL DE MINAS GERAIS Magister Nathalia Cristina de Jesus Pereira Noviembre 2016
UNIVERSIDADE FEDERAL DE MINAS GERAIS Magister Monica Santos Schneider Noviembre 2016
UNIVERSIDADE FEDERAL DE MINAS GERAIS Magister Marcelo Perdigão Oliveira Junio 2018
UNIVERSIDADE FEDERAL DE MINAS GERAIS Doctorado Lourena Emanuele Costa Noviembre 2016

Experiencia como evaluador y/o formulador de proyectos

Tipo de experiencia Ańo Tipo de proyecto Entidad financiadora Nombre del concurso Metodología de evaluación Monto proyecto (USD)
Experiencia como formulador(sólo proyectos ganados) 2012 Proyectos de Innovación CNPQ CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO Chamada Universal 14/2012 4500.0

Formación Académica (Fuente: SUNEDU)

Grado Título Centro de Estudios País de Estudios Fuente
DOCTORADO GRADO DE DOCTOR EN CIENCIAS (GRADO DE DOCTOR) UNIVERSIDADE FEDERAL DE MINAS GERAIS BRASIL
MAGISTER GRADO DE MAGÍSTER EN CIENCIAS BIOLÓGICAS: FARMACOLOGÍA BIOQUÍMICA Y MOLECULAR (GRADO DE MAESTRO) UNIVERSIDADE FEDERAL DE MINAS GERAIS BRASIL
SEGUNDA ESPECIALIDAD TÍTULO DE MÉDICO VETERINARIO (GRADO DE BACHILLER Y TÍTULO PROFESIONAL) UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO BRASIL

Formación Académica (Fuente: Manual)

Grado Título Centro de Estudios País de Estudios Fecha de inicio Fecha fin Fuente

Estudios Técnicos

Centro de estudios Carrera Fecha de Inicio Fecha de fin

Estudios académicos y/o técnicos superiores en curso

Centro de estudios Carrera Tipo de estudios Fecha de inicio

Formación Complementaria

Centro de estudios Capacitación complementaria Frecuencia Cantidad País de estudio Fecha de inicio Fecha fin

Idiomas

Idioma Lectura Conversación Escritura Forma de aprendizaje Lengua Materna
INGLES AVANZADO AVANZADO AVANZADO Estudio Instituto NO
FRANCES BÁSICO BÁSICO BÁSICO Autodidacta NO
PORTUGUES AVANZADO SUPERIOR AVANZADO SUPERIOR AVANZADO SUPERIOR Autodidacta NO

Línea de investigación

Área Sub área Disciplina Temática Ambiental Temática Médica y de la Salud
Ciencias Naturales Ciencias biológicas Bioquímica y biología molecular
Ciencias Agrícolas Ciencias Veterinarias Ciencias Veterinarias
Ciencias Naturales Computación y ciencias de la información Ciencias de la información y bioinformática
Ciencias Médicas y de la Salud Biotecnología en Salud Biotecnología relacionada con la salud Metaxénicas y zoonóticas

Producción científica

Tipo Producción Título Autor Año de Producción DOI Revista Fuente Cuartil de ScimagoJR o JCR*
Journal-article PeruNPDB: the Peruvian Natural Products Database for in silico drug screening. 2023 10.1038/S41598-023-34729-0 Miguel Angel Chávez Fumagalli a través de ORCID
Journal-article Computer-aided drug design approaches applied to screen natural product’s structural analogs targeting arginase in Leishmania spp [version 3; peer review: 2 approved, 1 approved with reservations] 2023 10.12688/F1000RESEARCH.129943.3 F1000 a través de ORCID
Journal-article Peruvian contributions to scientific publications on experimental research against COVID-19: a systematic review [version 2; peer review: 1 approved, 1 approved with reservations] 2023 10.12688/F1000RESEARCH.134989.2 F1000 a través de ORCID
Journal-article rMELEISH: A Novel Recombinant Multiepitope-Based Protein Applied to the Serodiagnosis of Both Canine and Human Visceral Leishmaniasis 2023 10.20944/PREPRINTS202212.0223.V1 Miguel Angel Chávez Fumagalli a través de ORCID
Preprint - preprint A Review of Major Patents on Potential Malaria Vaccine Targets, Including Antigens from Different Stages of The Parasite Cycle Mariano, Reysla Maria da Silveira | Goncalves, Ana Alice Maia | Oliveira, Diana Souza de | Ribeiro, Helen Silva | Pereira, Diogo Fonseca Soares | Santos, Ingrid Soares | Lair, Daniel Ferreira | Da Silva, Augusto Ventura | Galdino, Alexsandro Sobreira | Chavez-Fumagalli, Miguel Angel | da Silveira-Lemos, Denise | Dutra, Walderez Ornelas | Giunchetti, Rodolfo Cordeiro 2023 10.20944/PREPRINTS202301.0192 Preprints S/C***
Journal-article A Mini-Review on Potentials Proteins/Peptides Applied for Serodiagnosis of Human Monkeypox Infection and Future Trends. 2023 10.2174/0929866530666230328094425 Miguel Angel Chávez Fumagalli a través de ORCID
Journal-article A mini-review on ELISA-Based Diagnosis of Schistosomiasis. 2023 10.2174/1566524023666230504140828 Miguel Angel Chávez Fumagalli a través de ORCID
Preprint Identification of compounds from natural Peruvian sources as potential inhibitors of SARS-CoV-2 Mpro mutations by virtual screening and computational simulations 2023 10.26434/CHEMRXIV-2023-WDD12 Crossref a través de ORCID
Artículo en revista científica Co-occurring pathogenic variants in 6q27 associated with dementia spectrum disorders in a Peruvian family Alvarez K.L.F. 2023 10.3389/FNMOL.2023.1104585 Frontiers in Molecular Neuroscience 2023: No disponible**, 2020: Q1
Journal-article Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis 2023 10.3390/BIOLOGY12060851 Multidisciplinary Digital Publishing Institute a través de ORCID
Review A Systematic Review and Meta-Analysis Comparing the Diagnostic Accuracy Tests of COVID-19 Vilca-Alosilla J.J. 2023 10.3390/DIAGNOSTICS13091549 Diagnostics 2023: No disponible**, 2020: Q3
Review A Review of Major Patents on Potential Malaria Vaccine Targets Mariano R.M.d.S. 2023 10.3390/PATHOGENS12020247 Pathogens 2023: No disponible**, 2020: Q2
Artículo en revista científica rMELEISH: A Novel Recombinant Multiepitope-Based Protein Applied to the Serodiagnosis of Both Canine and Human Visceral Leishmaniasis Dias D.S. 2023 10.3390/PATHOGENS12020302 Pathogens 2023: No disponible**, 2020: Q2
Artículo en revista científica Proof of Concept of a Novel Multiepitope Recombinant Protein for the Serodiagnosis of Patients with Chagas Disease Machado J.M. 2023 10.3390/PATHOGENS12020312 Pathogens 2023: No disponible**, 2020: Q2
Artículo en revista científica Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis Soyer T.G. 2023 10.3390/PATHOGENS12020314 Pathogens 2023: No disponible**, 2020: Q2
Journal-article Navigating the Chemical Space and Chemical Multiverse of a Unified Latin American Natural Product Database: LANaPDB 2023 10.3390/PH16101388 Multidisciplinary Digital Publishing Institute a través de ORCID
Journal-article Vaccination with Formulation of Nanoparticles Loaded with <i>Leishmania amazonensis</i> Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster 2023 10.3390/VACCINES11010111 Multidisciplinary Digital Publishing Institute a través de ORCID
Artículo en revista científica Vaccination with Formulation of Nanoparticles Loaded with Leishmania amazonensis Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster González M.A.C. 2023 10.3390/VACCINES11010111 Vaccines 2023: No disponible**, 2020: Q1
Journal-article Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges 2023 10.3390/VACCINES11101565 Multidisciplinary Digital Publishing Institute a través de ORCID
Journal-article Advances in Non-Chemical Tools to Control Poultry Hematophagous Mites 2023 10.3390/VETSCI10100589 Miguel Angel Chávez Fumagalli a través de ORCID
Preprint A Systematic Review of Peruvian Contributions to Scientific Publications on Experimental Research Against COVID-19 2023 10.37766/INPLASY2023.4.0080 Miguel Angel Chávez Fumagalli a través de ORCID
JOURNAL_ARTICLE A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum 2022 10.1016/j.actatropica.2022.106412 Miguel Angel Chávez Fumagalli a través de ORCID
JOURNAL_ARTICLE Recombinant guanosine-5′-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infection 2022 10.1016/j.cyto.2022.155865 Miguel Angel Chávez Fumagalli a través de ORCID
Artículo en revista científica Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteins Galvani N.C. 2022 10.1016/j.micpath.2021.105341 Microbial Pathogenesis Q2
JOURNAL_ARTICLE Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasis 2022 10.1016/j.micpath.2022.105562 Miguel Angel Chávez Fumagalli a través de ORCID
JOURNAL_ARTICLE <i>Leishmania</i> LiHyC protein is immunogenic and induces protection against visceral leishmaniasis 2022 10.1111/pim.12921 Miguel Angel Chávez Fumagalli a través de ORCID
JOURNAL_ARTICLE Alzheimers Disease: A Silent Pandemic – A Systematic Review on the Situation and Patent Landscape of the Diagnosis 2022 10.2174/1872208316666220408114129 Miguel Angel Chávez Fumagalli a través de ORCID
Review Accuracy of Diagnostic Tests for the Detection of Chagas Disease: A Systematic Review and Meta-Analysis Candia-Puma M.A. 2022 10.3390/DIAGNOSTICS12112752 Diagnostics Q2
JOURNAL_ARTICLE In Silico Analysis of Metabolites from Peruvian Native Plants as Potential Therapeutics against Alzheimers Disease. 2022 10.3390/molecules27030918 Miguel Angel Chávez Fumagalli a través de ORCID
Artículo en revista científica A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection Lage D.P. 2022 10.3390/VACCINES10071146 Vaccines Q1
Artículo en revista científica Nanoformulations with Leishmania braziliensis Antigens Triggered Controlled Parasite Burden in Vaccinated Golden Hamster (Mesocricetus auratus) against Visceral Leishmaniasis Ottino J. 2022 10.3390/VACCINES10111848 Vaccines Q1
Article Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis Costa, Rafaella R. 2021 10.1007/s00430-021-00707-4 2021: No disponible**, 2020: Q3
Artículo en revista científica Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis Costa R.R. 2021 10.1007/s00430-021-00707-4 Medical Microbiology and Immunology Q2
Artículo en revista científica Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis Freitas C.S. 2021 10.1007/s00436-020-06971-2 Parasitology Research Q1
Article Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis Freitas, Camila S. 2021 10.1007/s00436-020-06971-2 2021: No disponible**, 2020: Q2
Artículo en revista científica Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary stu Santos T.T.O. 2021 10.1016/j.actatropica.2021.106126 Acta Tropica Q1
Article Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary study Santos, Thais T. O. 2021 10.1016/j.actatropica.2021.106126 2021: No disponible**, 2020: Q1
Artículo en revista científica Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis Reis T.A.R. 2021 10.1016/j.exppara.2020.108059 Experimental Parasitology Q3
Article Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis Reis, Thiago A. R. 2021 10.1016/j.exppara.2020.108059 2021: No disponible**, 2020: Q3
JOURNAL_ARTICLE Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study. 2021 10.1016/j.exppara.2021.108205 Miguel Angel Chávez Fumagalli a través de ORCID
Article Vascular smooth muscle cell dysfunction contribute to neuroinflammation and Tau hyperphosphorylation in Alzheimer disease Aguilar-Pineda, Jorge A. 2021 10.1016/j.isci.2021.102993 2021: No disponible**, 2020: Q1
Article Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection Santos, Thais T. O. 2021 10.1016/j.micpath.2021.104745 2021: No disponible**, 2020: Q2
Artículo en revista científica Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection Santos T.T.O. 2021 10.1016/j.micpath.2021.104745 Microbial Pathogenesis Q2
Artículo en revista científica Serodiagnosis of canine leishmaniasis using a novel recombinant chimeric protein constructed with distinct B-cell epitopes from antigenic Leishmania infantum proteins Vale D.L. 2021 10.1016/j.vetpar.2021.109513 Veterinary Parasitology Q1
Article Serodiagnosis of canine leishmaniasis using a novel recombinant chimeric protein constructed with distinct B-cell epitopes from antigenic Leishmania infantum proteins Vale, Danniele L. 2021 10.1016/j.vetpar.2021.109513 2021: No disponible**, 2020: Q1
Article Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfection Ramos, Fernanda F. 2021 10.1017/S0031182021001505 2021: No disponible**, 2020: Q2
Artículo en revista científica Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfection Ramos F.F. 2021 10.1017/S0031182021001505 Parasitology Q1
Article In vitro and in vivo antileishmanial activity of beta-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis Freitas, Camila S. 2021 10.1051/parasite/2021036 2021: No disponible**, 2020: Q2
Artículo en revista científica In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis Freitas C.S. 2021 10.1051/parasite/2021036 Parasite Q1
Review Diagnosis of Alzheimer's Disease in Developed and Developing Countries: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Chavez-Fumagalli, Miguel A. 2021 10.3233/ADR-200263 S/C***
Artículo en revista científica Antiviral activity of metabolites from peruvian plants against sars-cov-2: An in silico approach Goyzueta-Mamani L.D. 2021 10.3390/molecules26133882 Molecules Q1
Article Antiviral Activity of Metabolites from Peruvian Plants against SARS-CoV-2: An In Silico Approach Daniel Goyzueta-Mamani, Luis 2021 10.3390/molecules26133882 2021: No disponible**, 2020: Q2
Artículo en revista científica Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells Ribeiro P.A.F. 2020 10.1007/s00436-020-06752-x Parasitology Research Q1
Article Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells Ribeiro, Patricia A. F. 2020 10.1007/s00436-020-06752-x PARASITOLOGY RESEARCH Q2
Artículo en revista científica A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasis Machado A.S. 2020 10.1016/j.actatropica.2019.105318 Acta Tropica Q1
Article A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasis Machado, Amanda S. 2020 10.1016/j.actatropica.2019.105318 ACTA TROPICA Q1
Artículo en revista científica Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis Ribeiro P.A.F. 2020 10.1016/j.cyto.2020.155031 Cytokine Q1
Article Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis Ribeiro, Patricia A. F. 2020 10.1016/j.cyto.2020.155031 CYTOKINE Q3
Artículo en revista científica A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease Machado A.S. 2020 10.1016/j.exppara.2020.107941 Experimental Parasitology Q2
Article A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease Machado, Amanda S. 2020 10.1016/j.exppara.2020.107941 EXPERIMENTAL PARASITOLOGY Q3
Artículo en revista científica Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis Oliveira-da-Silva J.A. 2020 10.1016/j.imlet.2020.01.005 Immunology Letters Q2
Article Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis Oliveira-da-Silva, Joao A. 2020 10.1016/j.imlet.2020.01.005 IMMUNOLOGY LETTERS Q3
Artículo en revista científica Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasis Oliveira-da-Silva J.A. 2020 10.1016/j.micpath.2020.104283 Microbial Pathogenesis Q2
Article Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasis Oliveira-da-Silva, Joao A. 2020 10.1016/j.micpath.2020.104283 MICROBIAL PATHOGENESIS Q2
Article A clioquinol-containing Pluronic(R) F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model Tavares, Grasiele S. V. 2020 10.1051/parasite/2020027 Parasite Q2
Artículo en revista científica A clioquinol-containing Pluronic<sup>®</sup>F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model Tavares G.S.V. 2020 10.1051/parasite/2020027 Parasite Q1
Article Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis Pereira, Isabela A. G. 2020 10.1111/pim.12784 PARASITE IMMUNOLOGY Q3
Artículo en revista científica Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis Pereira I.A.G. 2020 10.1111/pim.12784 Parasite Immunology Q2
JOURNAL_ARTICLE Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis. 2020 10.1111/pim.12784 Miguel Angel Chávez Fumagalli a través de ORCID
Artículo en revista científica In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species Tavares G. 2019 10.1016/j.actatropica.2018.12.036 Acta Tropica Q1
Article In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species Tavares, Grasiele S. V. 2019 10.1016/j.actatropica.2018.12.036 ACTA TROPICA Q1
Article In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic (R) F127-based polymeric micelle system against Leishmania amazonensis infection Mendonca, Debora V. C. 2019 10.1016/j.biopha.2018.10.143 BIOMEDICINE & PHARMACOTHERAPY Q1
Artículo en revista científica In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic <sup>®</sup> F127-based polymeric micelle system against Leishmania amazonensis infection Mendonça D.V.C. 2019 10.1016/j.biopha.2018.10.143 Biomedicine and Pharmacotherapy Q1
Article Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controls Vale, Danniele L. 2019 10.1016/j.diagmicrobio.2019.04.015 DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE Q3
Artículo en revista científica Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controls Vale D. 2019 10.1016/j.diagmicrobio.2019.04.015 Diagnostic Microbiology and Infectious Disease Q1
Article Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis Soyer, Tauane G. 2019 10.1016/j.exppara.2019.02.019 EXPERIMENTAL PARASITOLOGY Q3
Artículo en revista científica Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis Soyer T.G. 2019 10.1016/j.exppara.2019.02.019 Experimental Parasitology Q2
Artículo en revista científica Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasis Salles B. 2019 10.1016/j.imbio.2018.09.003 Immunobiology Q2
Article Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasis Salles, Beatriz C. S. 2019 10.1016/j.imbio.2018.09.003 IMMUNOBIOLOGY Q3
Artículo en revista científica A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein Lage D. 2019 10.1016/j.imbio.2019.05.008 Immunobiology Q2
Article A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein Lage, Daniela P. 2019 10.1016/j.imbio.2019.05.008 IMMUNOBIOLOGY Q3
Article In silico Leishmania proteome mining applied to identify drug target potential to be used to treat against visceral and tegumentary leishmaniasis Chavez-Fumagalli, Miguel A. 2019 10.1016/j.jmgm.2018.11.014 JOURNAL OF MOLECULAR GRAPHICS & MODELLING Q2
Artículo en revista científica In silico Leishmania proteome mining applied to identify drug target potential to be used to treat against visceral and tegumentary leishmaniasis Chávez-Fumagalli M. 2019 10.1016/j.jmgm.2018.11.014 Journal of Molecular Graphics and Modelling Q2
Artículo en revista científica Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans Santos T.T.O. 2019 10.1016/j.micpath.2019.103783 Microbial Pathogenesis Q2
Article Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans Santos, Thais T. O. 2019 10.1016/j.micpath.2019.103783 MICROBIAL PATHOGENESIS Q3
Artículo en revista científica Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection Ribeiro P.A.F. 2019 10.1016/j.molimm.2018.12.025 Molecular Immunology Q2
Article Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection Ribeiro, Patricia A. F. 2019 10.1016/j.molimm.2018.12.025 MOLECULAR IMMUNOLOGY Q2
Artículo en revista científica A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection Tavares G.S.V. 2019 10.1016/j.parint.2018.10.005 Parasitology International Q2
Article A Pluronic (R) F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection Tavares, Grasiele S. V. 2019 10.1016/j.parint.2018.10.005 PARASITOLOGY INTERNATIONAL Q3
Article A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis Sousa, Jessica K. T. 2019 10.1016/j.parint.2019.101966 PARASITOLOGY INTERNATIONAL Q3
Artículo en revista científica A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis Sousa J.K.T. 2019 10.1016/j.parint.2019.101966 Parasitology International Q2
Article High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection Carvalho, Gerusa B. 2019 10.1017/S0031182018001403 PARASITOLOGY Q2
Artículo en revista científica High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection Carvalho G.B. 2019 10.1017/S0031182018001403 Parasitology Q1
Article Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach Lage, Daniela P. 2019 10.1017/S0031182019000714 PARASITOLOGY Q2
Artículo en revista científica Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach Lage D.P. 2019 10.1017/S0031182019000714 Parasitology Q1
Artículo en revista científica Large expert-curated database for benchmarking document similarity detection in biomedical literature search Brown P. 2019 10.1093/database/baz085 Database : the journal of biological databases and curation Q1
Article Large expert-curated database for benchmarking document similarity detection in biomedical literature search Brown, Peter 2019 10.1093/database/baz085 Database-The Journal of Biological Databases and Curation Q2
Article Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L-amazonensis species Costa Mendonca, Debora Vasconcelos 2018 10.1007/s00436-017-5713-6 PARASITOLOGY RESEARCH Q2
Artículo en revista científica Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species Mendonça D. 2018 10.1007/s00436-017-5713-6 Parasitology Research Q1
Artículo en revista científica Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis Dias D.S. 2018 10.1016/j.cellimm.2017.11.001 Cellular Immunology Q2
Article Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis Dias, Daniel S. 2018 10.1016/j.cellimm.2017.11.001 CELLULAR IMMUNOLOGY Q2
Artículo en revista científica Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans Ribeiro P.A.F. 2018 10.1016/j.cellimm.2018.05.009 Cellular Immunology Q2
Article Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans Ribeiro, Patricia A. F. 2018 10.1016/j.cellimm.2018.05.009 CELLULAR IMMUNOLOGY Q2
Artículo en revista científica Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individuals Lima M. 2018 10.1016/j.cellimm.2018.09.006 Cellular Immunology Q2
Article Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individuals Lima, Mariana P. 2018 10.1016/j.cellimm.2018.09.006 CELLULAR IMMUNOLOGY Q2
Article A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis Ribeiro, Patricia A. F. 2018 10.1016/j.cyto.2018.08.019 CYTOKINE Q2
Artículo en revista científica A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis Ribeiro P. 2018 10.1016/j.cyto.2018.08.019 Cytokine Q1
Article A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-up Ribeiro, Patricia A. F. 2018 10.1016/j.diagmicrobio.2018.05.026 DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE Q3
Artículo en revista científica A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-up Ribeiro P. 2018 10.1016/j.diagmicrobio.2018.05.026 Diagnostic Microbiology and Infectious Disease Q1
Article Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis Portela, Aquila S. B. 2018 10.1016/j.imbio.2017.10.043 IMMUNOBIOLOGY Q3
Artículo en revista científica Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis Portela Á.S.B. 2018 10.1016/j.imbio.2017.10.043 Immunobiology Q2
Article Serological diagnosis and prognostic of tegumentary and visceral leishmaniasis using a conserved Leishmania hypothetical protein Dias, Daniel S. 2018 10.1016/j.parint.2018.02.001 PARASITOLOGY INTERNATIONAL Q2
Artículo en revista científica Serological diagnosis and prognostic of tegumentary and visceral leishmaniasis using a conserved Leishmania hypothetical protein Dias D.S. 2018 10.1016/j.parint.2018.02.001 Parasitology International Q2
Article Vaccination with a CD4(+) and CD8(+) T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis Dias, Daniel S. 2018 10.1016/j.trsl.2018.05.001 Translational Research Q1
Artículo en revista científica Vaccination with a CD4 <sup>+</sup> and CD8 <sup>+</sup> T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis Dias D.S. 2018 10.1016/j.trsl.2018.05.001 Translational Research Q1
Artículo en revista científica Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis Dias D.S. 2018 10.1017/S0031182017001731 Parasitology Q1
Article Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis Dias, Daniel S. 2018 10.1017/S0031182017001731 PARASITOLOGY Q2
Article Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species Vieira Tavares, Grasiele de Sousa 2018 10.1111/bcpt.12990 BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY Q3
Artículo en revista científica Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species Tavares G. 2018 10.1111/bcpt.12990 Basic and Clinical Pharmacology and Toxicology Q2
Article A Computational Approach Using Bioinformatics to Screening Drug Targets for Leishmania infantum Species Chavez-Fumagalli, Miguel Angel 2018 10.1155/2018/6813467 Evidence-based Complementary and Alternative Medicine Q2
Artículo en revista científica A Computational Approach Using Bioinformatics to Screening Drug Targets for Leishmania infantum Species Chávez-Fumagalli M. 2018 10.1155/2018/6813467 Evidence-based Complementary and Alternative Medicine Q1
Artículo en revista científica Small myristoylated protein-3, identified as a potential virulence factor in Leishmania amazonensis, proves to be a protective antigen against visceral leishmaniasis Oliveira M.P. 2018 10.3390/ijms19010129 International Journal of Molecular Sciences Q1
Article Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis Oliveira, Marcelo P. 2018 10.3390/ijms19010129 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES Q2
Article Evaluation of a hypothetical protein for serodiagnosis and as a potential marker for post-treatment serological evaluation of tegumentary leishmaniasis patients Lima, Mariana Pedrosa 2017 10.1007/s00436-017-5397-y PARASITOLOGY RESEARCH Q2
Artículo en revista científica Evaluation of a hypothetical protein for serodiagnosis and as a potential marker for post-treatment serological evaluation of tegumentary leishmaniasis patients Lima M. 2017 10.1007/s00436-017-5397-y Parasitology Research Q1
Article Probing the efficacy of a heterologous Leishmania/L-Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB/c mice Santos, Thais T. O. 2017 10.1016/j.actatropica.2017.03.008 ACTA TROPICA Q2
Artículo en revista científica Probing the efficacy of a heterologous Leishmania/L. Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB/c mice Santos T.T.O. 2017 10.1016/j.actatropica.2017.03.008 Acta Tropica Q1
Article An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humans Carvalho, Ana Maria R. S. 2017 10.1016/j.cellimm.2017.06.001 CELLULAR IMMUNOLOGY Q3
Artículo en revista científica An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humans Carvalho A. 2017 10.1016/j.cellimm.2017.06.001 Cellular Immunology Q2
Article Leishmania infantum mimotopes and a phage-ELISA assay as tools for a sensitive and specific serodiagnosis of human visceral leishmaniasis Salles, Beatriz C. S. 2017 10.1016/j.diagmicrobio.2016.11.012 DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE Q3
Artículo en revista científica Leishmania infantum mimotopes and a phage–ELISA assay as tools for a sensitive and specific serodiagnosis of human visceral leishmaniasis Salles B. 2017 10.1016/j.diagmicrobio.2016.11.012 Diagnostic Microbiology and Infectious Disease Q1
Artículo en revista científica An in silico functional annotation and screening of potential drug targets derived from Leishmania spp. hypothetical proteins identified by immunoproteomics Chávez-Fumagalli M. 2017 10.1016/j.exppara.2017.03.005 Experimental Parasitology Q2
Article An in silico functional annotation and screening of potential drug targets derived from Leishmania spp. hypothetical proteins identified by immunoproteomics Chavez-Fumagalli, Miguel A. 2017 10.1016/j.exppara.2017.03.005 EXPERIMENTAL PARASITOLOGY Q3
Article Antigenicity of phage clones and their synthetic peptides for the serodiagnosis of canine and human visceral leishmaniasis Costa, Lourena E. 2017 10.1016/j.micpath.2017.06.020 MICROBIAL PATHOGENESIS Q3
Artículo en revista científica Antigenicity of phage clones and their synthetic peptides for the serodiagnosis of canine and human visceral leishmaniasis Costa L. 2017 10.1016/j.micpath.2017.06.020 Microbial Pathogenesis Q2
Artículo en revista científica Recombinant small glutamine-rich tetratricopeptide repeat-containing protein of Leishmania infantum: Potential vaccine and diagnostic application against visceral leishmaniasis Dias D.S. 2017 10.1016/j.molimm.2017.09.017 Molecular Immunology Q2
Article Recombinant small glutamine-rich tetratricopeptide repeat-containing protein of Leishmania infantum: Potential vaccine and diagnostic application against visceral leishmaniasis Dias, Daniel S. 2017 10.1016/j.molimm.2017.09.017 MOLECULAR IMMUNOLOGY Q2
Article Performance of Leishmania braziliensis enolase protein for the serodiagnosis of canine and human visceral leishmaniosis Duarte, Mariana Costa 2017 10.1016/j.vetpar.2017.03.024 VETERINARY PARASITOLOGY Q1
Artículo en revista científica Performance of Leishmania braziliensis enolase protein for the serodiagnosis of canine and human visceral leishmaniosis Duarte M.C. 2017 10.1016/j.vetpar.2017.03.024 Veterinary Parasitology Q1
Artículo en revista científica Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection Ramos F.F. 2017 10.1186/s13071-017-2576-8 Parasites and Vectors Q1
Article Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection Ramos, Fernanda Fonseca 2017 10.1186/s13071-017-2576-8 Parasites & Vectors Q1
Artículo en revista científica A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis Lage D.P. 2016 10.1007/s00436-016-4904-x Parasitology Research Q1
Article A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis Lage, Daniela P. 2016 10.1007/s00436-016-4904-x PARASITOLOGY RESEARCH Q2
Article A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis Martins, Vivian Tamietti 2016 10.1016/j.actatropica.2015.11.006 ACTA TROPICA Q2
Artículo en revista científica A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis Martins V.T. 2016 10.1016/j.actatropica.2015.11.006 Acta Tropica Q1
Artículo en revista científica Cross-protective efficacy of Leishmania infantum LiHyD protein against tegumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species Lage D.P. 2016 10.1016/j.actatropica.2016.03.011 Acta Tropica Q1
Article Cross-protective efficacy of Leishmania infantum LiHyD protein against tegumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species Lage, Daniela Pagliara 2016 10.1016/j.actatropica.2016.03.011 ACTA TROPICA Q2
Article Antileishmanial activity and mechanism of action from a purified fraction of Zingiber officinalis Roscoe against Leishmania amazonensis Duarte, Mariana C. 2016 10.1016/j.exppara.2016.03.026 EXPERIMENTAL PARASITOLOGY Q3
Artículo en revista científica Antileishmanial activity and mechanism of action from a purified fraction of Zingiber officinalis Roscoe against Leishmania amazonensis Duarte M.C. 2016 10.1016/j.exppara.2016.03.026 Experimental Parasitology Q2
Article Poloxamer 407 (Pluronic (R) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis Mendonca, Debora V. C. 2016 10.1016/j.exppara.2016.07.005 EXPERIMENTAL PARASITOLOGY Q3
Artículo en revista científica Poloxamer 407 (Pluronic<sup>®</sup> F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis Mendonça D. 2016 10.1016/j.exppara.2016.07.005 Experimental Parasitology Q2
Article New serological tools for improved diagnosis of human tegumentary leishmaniasis Costa, Lourena E. 2016 10.1016/j.jim.2016.04.005 JOURNAL OF IMMUNOLOGICAL METHODS Q3
Artículo en revista científica New serological tools for improved diagnosis of human tegumentary leishmaniasis Costa L. 2016 10.1016/j.jim.2016.04.005 Journal of Immunological Methods Q2
Article Evaluation of two recombinant Leishmania proteins identified by an immunoproteomic approach as tools for the serodiagnosis of canine visceral and human tegumentary leishmaniasis Ferraz Coelho, Eduardo Antonio 2016 10.1016/j.vetpar.2015.11.006 VETERINARY PARASITOLOGY Q1
Artículo en revista científica Evaluation of two recombinant Leishmania proteins identified by an immunoproteomic approach as tools for the serodiagnosis of canine visceral and human tegumentary leishmaniasis Coelho E.A.F. 2016 10.1016/j.vetpar.2015.11.006 Veterinary Parasitology Q1
Artículo en revista científica Cross-protective efficacy from a immunogen firstly identified in Leishmania infantum against tegumentary leishmaniasis Martins V.T. 2016 10.1111/pim.12304 Parasite Immunology Q2
Article Cross-protective efficacy from a immunogen firstly identified in Leishmania infantum against tegumentary leishmaniasis Martins, V. T. 2016 10.1111/pim.12304 PARASITE IMMUNOLOGY Q2
Review Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis Duarte M.C. 2016 10.1590/0037-8682-0120-2016 Revista da Sociedade Brasileira de Medicina Tropical Q3
Review Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis Duarte, Mariana Costa 2016 10.1590/0037-8682-0120-2016 Revista da Sociedade Brasileira de Medicina Tropical Q3
Artículo en revista científica A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis. Lage DP 2016 Parasitology research No Aplica
Artículo en revista científica A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis. Martins VT 2016 Acta tropica No Aplica
Artículo en revista científica Antileishmanial activity and mechanism of action from a purified fraction of Zingiber officinalis Roscoe against Leishmania amazonensis. Duarte MC 2016 Experimental parasitology No Aplica
Artículo en revista científica Cross-protective efficacy of Leishmania infantum LiHyD protein against tegumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species. Lage DP 2016 Acta tropica No Aplica
Artículo en revista científica Evaluation of two recombinant Leishmania proteins identified by an immunoproteomic approach as tools for the serodiagnosis of canine visceral and human tegumentary leishmaniasis. Coelho EA 2016 Veterinary parasitology No Aplica
Artículo en revista científica New serological tools for improved diagnosis of human tegumentary leishmaniasis. Costa LE 2016 Journal of immunological methods No Aplica
Meeting Abstract Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis Costa, L. E. 2015 TROPICAL MEDICINE & INTERNATIONAL HEALTH No Aplica
Artículo en revista científica Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum Lage P.S. 2015 10.1007/s00436-015-4708-4 Parasitology Research Q1
Article Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum Lage, Paula S. 2015 10.1007/s00436-015-4708-4 PARASITOLOGY RESEARCH Q2
Artículo en revista científica Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis de Jesus Pereira N.C. 2015 10.1016/j.exppara.2015.03.027 Experimental Parasitology Q2
Article Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis de Jesus Pereira, Nathalia Cristina 2015 10.1016/j.exppara.2015.03.027 EXPERIMENTAL PARASITOLOGY Q3
Article Antileishmanial activity of standardized fractions of Stryphnodendron obovatum (Barbatimao) extract and constituent compounds Ribeiro, Tatiana G. 2015 10.1016/j.jep.2015.02.047 JOURNAL OF ETHNOPHARMACOLOGY Q1
Artículo en revista científica Antileishmanial activity of standardized fractions of Stryphnodendron obovatum (Barbatimão) extract and constituent compounds Ribeiro T.G. 2015 10.1016/j.jep.2015.02.047 Journal of Ethnopharmacology Q1
Artículo en revista científica Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection Costa L.E. 2015 10.1017/S0031182015000724 Parasitology Q1
Article Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection Costa, Lourena Emanuele 2015 10.1017/S0031182015000724 PARASITOLOGY Q2
Article Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis Lage, D. P. 2015 10.1111/pim.12287 PARASITE IMMUNOLOGY Q2
Artículo en revista científica Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis Lage D.P. 2015 10.1111/pim.12287 Parasite Immunology Q2
Artículo en revista científica Proteins selected in Leishmania (Viannia) braziliensis by an immunoproteomic approach with potential serodiagnosis applications for tegumentary leishmaniasis Duarte M.C. 2015 10.1128/CVI.00465-15 Clinical and Vaccine Immunology Q1
Article Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis Duarte, Mariana C. 2015 10.1128/CVI.00465-15 S/C***
Artículo en revista científica A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis Martins V.T. 2015 10.1186/s13071-015-0964-5 Parasites and Vectors Q1
Article A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis Martins, Vivian T. 2015 10.1186/s13071-015-0964-5 Parasites & Vectors Q1
Artículo en revista científica Antigenicity, immunogenicity and protective efficacy of three proteins expressed in the promastigote and amastigote stages of leishmania infantum against visceral leishmaniasis Martins V.T. 2015 10.1371/journal.pone.0137683 PLoS ONE Q1
Article Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis Martins, Vivian Tamietti 2015 10.1371/journal.pone.0137683 PLoS One Q1
Correction Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis (vol 10, e0137683, 2015) Martins, Vivian Tamietti 2015 10.1371/journal.pone.0141496 PLoS One No Aplica
Erratum Erratum: Antigenicity, immunogenicity and protective efficacy of three proteins expressed in the promastigote and amastigote stages of leishmania infantum against visceral leishmaniasis (PLoS ONE (2015) 10:9 (e0137683) DOI:10.1371/journal.pone.013768 Martins V.T. 2015 10.1371/journal.pone.0141496 PLoS ONE No Aplica
Review Theranostic applications of phage display to control leishmaniasis: selection of biomarkers for serodiagnostics, vaccination, and immunotherapy Ferraz Coelho, Eduardo Antonio 2015 10.1590/0037-8682-0096-2015 Revista da Sociedade Brasileira de Medicina Tropical Q3
Review Theranostic applications of phage display to control leishmaniasis: Selection of biomarkers for serodiagnostics, vaccination, and immunotherapy Coelho E.A.F. 2015 10.1590/0037-8682-0096-2015 Revista da Sociedade Brasileira de Medicina Tropical Q3
Review New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment Chávez-Fumagalli M.A. 2015 10.1590/0037-8682-0138-2015 Revista da Sociedade Brasileira de Medicina Tropical Q3
Review New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment Chavez-Fumagalli, Miguel Angel 2015 10.1590/0037-8682-0138-2015 Revista da Sociedade Brasileira de Medicina Tropical Q3
Artículo en revista científica A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis. Martins VT 2015 Parasites & vectors No Aplica
Artículo en revista científica A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis. Martins VT 2015 Acta tropica No Aplica
Artículo en revista científica Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis. Martins VT 2015 PloS one No Aplica
Artículo en revista científica Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum. Lage PS 2015 Parasitology research No Aplica
Artículo en revista científica Antileishmanial activity of standardized fractions of Stryphnodendron obovatum (Barbatimão) extract and constituent compounds. Ribeiro TG 2015 Journal of ethnopharmacology No Aplica
Artículo en revista científica Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis. de Jesus Pereira NC 2015 Experimental parasitology No Aplica
Artículo en revista científica New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment. Chávez-Fumagalli MA 2015 Revista da Sociedade Brasileira de Medicina Tropical No Aplica
Artículo en revista científica Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection. Costa LE 2015 Parasitology No Aplica
Artículo en revista científica Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis. Lage DP 2015 Parasite immunology No Aplica
Artículo en revista científica Proteins selected in Leishmania (Viannia) braziliensis by an immunoproteomic approach with potential serodiagnosis applications for tegumentary leishmaniasis. Duarte MC 2015 Clinical and vaccine immunology : CVI No Aplica
Artículo en revista científica Theranostic applications of phage display to control leishmaniasis: selection of biomarkers for serodiagnostics, vaccination, and immunotherapy. Coelho EA 2015 Revista da Sociedade Brasileira de Medicina Tropical No Aplica
Article Antileishmanial activity and cytotoxicity of Brazilian plants Ribeiro, Tatiana G. 2014 10.1016/j.exppara.2014.05.004 EXPERIMENTAL PARASITOLOGY Q3
Artículo en revista científica Antileishmanial activity and cytotoxicity of Brazilian plants Ribeiro T. 2014 10.1016/j.exppara.2014.05.004 Experimental Parasitology Q2
Artículo en revista científica Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic leishmania infantum antigens with potential serodiagnosis applications Costa L.E. 2014 10.1128/CVI.00583-13 Clinical and Vaccine Immunology Q1
Article Subtractive Phage Display Selection from Canine Visceral Leishmaniasis Identifies Novel Epitopes That Mimic Leishmania infantum Antigens with Potential Serodiagnosis Applications Costa, Lourena E. 2014 10.1128/CVI.00583-13 S/C***
Article Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis Ramirez, Laura 2014 10.1186/1756-3305-7-3 Parasites & Vectors Q1
Artículo en revista científica Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis Ramirez L. 2014 10.1186/1756-3305-7-3 Parasites and Vectors Q1
Artículo en revista científica Identification of Differentially Expressed Proteins from Leishmania amazonensis Associated with the Loss of Virulence of the Parasites Magalhães R.D.M. 2014 10.1371/journal.pntd.0002764 PLoS Neglected Tropical Diseases Q1
Article Identification of Differentially Expressed Proteins from Leishmania amazonensis Associated with the Loss of Virulence of the Parasites Magalhaes, Rubens D. M. 2014 10.1371/journal.pntd.0002764 PLoS Neglected Tropical Diseases Q1
Article Mimotope-Based Vaccines of Leishmania infantum Antigens and Their Protective Efficacy against Visceral Leishmaniasis Costa, Lourena Emanuele 2014 10.1371/journal.pone.0110014 PLoS One Q1
Article Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system Ribeiro, Tatiana G. 2014 10.2147/IJN.S55678 International Journal of Nanomedicine Q1
Artículo en revista científica An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis Ribeiro T. 2014 10.2147/IJN.S68966 International Journal of Nanomedicine Q1
Article An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis Ribeiro, Tatiana G. 2014 10.2147/IJN.S68966 International Journal of Nanomedicine Q1
Artículo en revista científica An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis. Ribeiro TG 2014 International journal of nanomedicine No Aplica
Artículo en revista científica Mimotope-Based Vaccines of Leishmania infantum Antigens and Their Protective Efficacy against Visceral Leishmaniasis. Costa LE 2014 PloS one No Aplica
Artículo en revista científica Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system. Ribeiro TG 2014 International journal of nanomedicine No Aplica
Artículo en revista científica Sensitive and specific serodiagnosis of Leishmania infantum infection in dogs by using peptides selected from hypothetical proteins identified by an immunoproteomic approach Chávez-Fumagalli M.A. 2013 10.1128/CVI.00023-13 Clinical and Vaccine Immunology Q1
Article Sensitive and Specific Serodiagnosis of Leishmania infantum Infection in Dogs by Using Peptides Selected from Hypothetical Proteins Identified by an Immunoproteomic Approach Chavez-Fumagalli, Miguel A. 2013 10.1128/CVI.00023-13 S/C***
Artículo en revista científica Strychnos pseudoquina and its purified compounds present an effective in vitro antileishmanial activity Lage P.S. 2013 10.1155/2013/304354 Evidence-based Complementary and Alternative Medicine Q1
Article Strychnos pseudoquina and Its Purified Compounds Present an Effective In Vitro Antileishmanial Activity Lage, Paula Sousa 2013 10.1155/2013/304354 Evidence-based Complementary and Alternative Medicine Q2
Artículo en revista científica Antigenicity and Protective Efficacy of a Leishmania Amastigote-specific Protein, Member of the Super-oxygenase Family, against Visceral Leishmaniasis Martins V.T. 2013 10.1371/journal.pntd.0002148 PLoS Neglected Tropical Diseases Q1
Article Antigenicity and Protective Efficacy of a Leishmania Amastigote-specific Protein, Member of the Super-oxygenase Family, against Visceral Leishmaniasis Martins, Vivian T. 2013 10.1371/journal.pntd.0002148 PLoS Neglected Tropical Diseases Q1
Artículo en revista científica Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites Oliveira D.M. 2012 10.1007/s00436-011-2628-5 Parasitology Research Q1
Article Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites Oliveira, Dulcilene M. 2012 10.1007/s00436-011-2628-5 PARASITOLOGY RESEARCH Q2
Article Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis Valadares, Diogo G. 2012 10.1007/s00436-012-3028-1 PARASITOLOGY RESEARCH Q2
Artículo en revista científica Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis Valadares D.G. 2012 10.1007/s00436-012-3028-1 Parasitology Research Q1
Artículo en revista científica Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis Valadares D.G. 2012 10.1016/j.exppara.2012.07.005 Experimental Parasitology Q2
Article Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis Valadares, Diogo G. 2012 10.1016/j.exppara.2012.07.005 EXPERIMENTAL PARASITOLOGY Q3
Artículo en revista científica Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach Coelho V.T.S. 2012 10.1371/journal.pntd.0001430 PLoS Neglected Tropical Diseases Q1
Article Identification of Proteins in Promastigote and Amastigote-like Leishmania Using an Immunoproteomic Approach Coelho, Vinicio T. S. 2012 10.1371/journal.pntd.0001430 PLoS Neglected Tropical Diseases Q1
Article Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species Valadares, Diogo G. 2011 10.1016/j.parint.2011.06.001 PARASITOLOGY INTERNATIONAL Q2
Artículo en revista científica Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species Valadares D. 2011 10.1016/j.parint.2011.06.001 Parasitology International Q2
Artículo en revista científica Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge Chávez-Fumagalli M.A. 2010 10.1016/j.micinf.2010.06.008 Microbes and Infection Q1
Article Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge Chavez-Fumagalli, Miguel A. 2010 10.1016/j.micinf.2010.06.008 MICROBES AND INFECTION Q2
Artículo en revista científica Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts Coelho E.A.F. 2009 10.1128/CVI.00295-09 Clinical and Vaccine Immunology Q1
Article Specific Serodiagnosis of Canine Visceral Leishmaniasis Using Leishmania Species Ribosomal Protein Extracts Coelho, Eduardo A. F. 2009 10.1128/CVI.00295-09 S/C***

* Sólo se presentan los cuartiles para la producción tipo artículos y review.

** Cuartil no disponible para el año de la publicación.

*** La revista no tiene cuartil en el año de la publicación.


Otras Producciones

Tipo de Producción Título Año de Producción Título de la fuente
ARTÍCULO EN CONGRESO Specific serodiagnosis of canine visceral leishmaniasis using peptides selected from hypothetical proteins identified by an immunoproteomic approach 2013 WorldLeish5 - Fifth World Congress on Leishmaniasis, 201...
ARTÍCULO EN CONGRESO Evaluation of the in vitro antileishmanial activity using different compositions obtained from chitosan. 2013 WorldLeish5 - Fifth World Congress on Leishmaniasis, 201...
ARTÍCULO EN CONGRESO Antigenicity and protective efficacy of a Leishmania amastigote-specific hypothetical protein against visceral leishmaniasis 2013 WorldLeish5 - Fifth World Congress on Leishmaniasis, 201...
ARTÍCULO EN CONGRESO Protective response induced by immunization with a recombinant bacteriophages-based vaccine selected by phage display against Leishmania amazonensis 2013 WorldLeish5 - Fifth World Congress on Leishmaniasis, 201...
ARTÍCULO EN CONGRESO Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania amazonensis challenge infection 2010 Anais do XXXV Congresso da Sociedade Brasileira de Imuno...

Proyectos de Investigación

Tipo Proyecto Título Descripción Institución Fecha de Inicio Fecha Fin Inv. Principal Área OCDE
Identificación de proteínas de virulencia en Leishmania amazonensis por análisis inmunoproteômica y su aplicación en el desarrollo de vacunas contra las Leishmaniasis La busqueda por nuevos antígenos de Leishmania, que presentem funciones biológicas destacadas como, por exemplo, fatores de virulencia y que, cuando utilizados como imunógenos, puedan ser capazes de induzir protección contra la infección por Leishmania se ha vuelto una alternativa interesante. En este proyecto, uma analisis imunoproteômica, será utilizada para la identificación de proteínas de virulência a partir de extratos protéicos de formas promastigotas metacíclicas de L. amazonensis. UNIVERSIDADE FEDERAL DE MINAS GERAIS Junio 2013 Junio 2015 MIGUEL ANGEL CHAVEZ FUMAGALLI Ciencias Médicas y de la Salud
Selección de péptidos sintéticos por Phage Display con aplicación en el diagnóstico específico de la leishmaniasis visceral canina Este trabajo tiene como objetivo el uso de la técnica de Phage Display para la detección de péptidos que puedan reconocidos por los anticuerpos presentes en los sueros de los perros con leishmaniasis visceral para permitir su diagnóstico serológico específico. UNIVERSIDADE FEDERAL DE MINAS GERAIS Agosto 2009 EDUARDO COELHO
Proteínas ribosomales de Leishmania (LRPs) empleadas como vacuna contra la infección por Leishmania chagasi y Leishmania amazonensis en ratones BALB/c Este proyecto pretende analizar la eficacacia protectora de las proteínas ribosomales de Leishmania amazonensis como vacuna de antígeno contra la infección experimental por L. chagasi o L. amazonensis en ratones BALB/c. UNIVERSIDAD AUTONOMA DE MADRID Julio 2008 Julio 2012 MANUEL SOTO
Desarrollo de productos farmacéuticos en forma de polímeros conjugados Sintetizar polímeros conjugados de quitosana, con drogas del arsenal terapéutico para mejorar su biodisponibilidad, cambiar las propiedades fisico-químicas, minimizar los efectos tóxicos y el desarrollo de nuevos productos farmacéuticos. UNIVERSIDADE FEDERAL DE MINAS GERAIS Mayo 2011 ANDRE GOMES FARACO
Proyectos de investigación Estudios moleculares e histopatológicos de la infestación por Sarcocystis aucheniae en llamas (Lama glama) y alpacas (Vicugna pacos) La carne de alpaca y llama, presenta un alto valor proteico y es considerada la mejor alternativa para la seguridad alimentaria de los pobladores altoandinos. Además, tiene un gran atractivo para la cocina gourmet, por su buen sabor, bajo contenido graso, alto contenido proteico y por tener nulo impacto ecológico. Su comercialización se ve muy afectada por la infestación con quistes macroscópicos, como granos de arroz, que se encuentran en el músculo de los animales y son a consecuencia de la in UNIVERSIDAD CATÓLICA DE SANTA MARIA Agosto 2022 Agosto 2024 MIGUEL ANGEL CHAVEZ FUMAGALLI
Proyectos de investigación ANÁLISIS PROTEÓMICO POR HERRAMIENTAS DE BIOLOGÍA COMPUTACIONAL, APLICADAS EN EL DESARROLLO DE PRUEBAS DE DIAGNÓSTICO RÁPIDO Y DE BAJO COSTO PARA LA RABIA HUMANA Y CANINA Son consideradas por la Organización Mundial de la Salud enfermedades tropicales desatendidas, un conjunto de enfermedades infecciosas causadas por protozoarios, virus, parásitos helmintos y bacterias, que afectan principalmente a las poblaciones más pobres. La Rabia aun es considerada endémica en el Perú y ocasiona un significativo impacto financiero en el sistema de salud pública, para responder la atención de accidentes de mordedura y la puesta de un sistema de vigilancia y administración de UNIVERSIDAD CATÓLICA DE SANTA MARIA Enero 2022 MIGUEL ANGEL CHAVEZ FUMAGALLI
Proyectos de investigación Desarrollo de plataformas de diagnóstico rápido, para la Leishmaniasis y el mal de Chagas, basadas en la combinación de Biología Computacional y ensayos inmunológicos Son consideradas por la Organización Mundial de la Salud enfermedades tropicales desatendidas, un conjunto de enfermedades infecciosas causadas por protozoarios, virus, parásitos helmintos y bacterias, que afectan principalmente a las poblaciones más pobres. Enfermedades como la Leishmaniasis y el mal de Chagas afectan ancestralmente a nuestra populación y aun son consideradas endémicas en el Perú. No hay vacuna contra ninguna de estas enfermedades y el tratamiento de pacientes debe sopesarse co UNIVERSIDAD CATÓLICA DE SANTA MARIA Julio 2022 Julio 2024 MIGUEL ANGEL CHAVEZ FUMAGALLI

Proyectos importados de ORCID

Tipo de financiamiento Título Descripción Institución Fecha de Inicio Fecha de Fin

Derechos de Propiedad Intelectual

Título de la Propiedad Intelectual (PI) Tipo de PI Entidad donde se tramitó la PI País Nombre del propietario de la PI Trámite vía PCT Estado de la patente Número de registrode la PI Rol de participación Participación en los derechos de la PI
Actividad leishmanicida del extracto de jengibre y sus fracciones Patente de invención Otros BRASIL Otorgada Parte del equipo de (I+D) Si
Método, test inmunodiagnóstico para la Leishmaniasis Visceral canina Patente de invención Otros BRASIL Otorgada Parte del equipo de (I+D) Si
Sistema nano particulado basado en quitosana y condroitina para el tratamiento de las Leishmaniasis Patente de invención Otros BRASIL Otorgada Parte del equipo de (I+D) Si
Proteína recombinante, método y test para el diagnóstico de las Leishmaniasis Visceral y Tegumentar en humanos y canes Patente de invención Otros BRASIL Otorgada Parte del equipo de (I+D) Si
Composición farmacéutica leishmanicida con Miglitol y formulaciones Patente de invención Otros BRASIL En trámite Parte del equipo de (I+D) Si

Productos de Desarrollo Industrial

Denominación Tipo de desarrollo Tipo de participación Estado del desarrollo Alcance del desarrollo Estado del uso del desarrollo Propietario del desarrollo

Distinciones y Premios

Institución Distinción Descripción País Web Referencia
UNIVERSIDADE FEDERAL DE MINAS GERAIS Premio a la Mejor Tesis Doctoral de la Universidad Federal De Minas Gerais. 2017. Grandes Áreas: Agrarias, Biológicas y Ciencias de la Salud Co asesor de tesis de Lourena Emanuele Costa BRASIL
COORDENAÇÃO DE APERFEIÇOAMENTO DE PESSOAL DE NIVEL SUPERIOR - CAPES Premio Nacional Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)-Interfama en Investigación Científica e Innovación a la Mejor Tesis Doctoral. 2017. Mención Honrosa Co asesor de tesis de Lourena Emanuele Costa BRASIL http://www.capes.gov.br/pt/36-noticias/8634-premio-capes-interfarma-premia-teses-de-doutorado-na-area-de-saude-humana
Contactar investigador Aquí

Los investigadores son responsables por los datos que consignen en la ficha personal del Directorio Nacional de Investigadores en CTeI, la cual podrá ser verificada en cualquier oportunidad por el CONCYTEC.

De comprobarse fraude o falsedad de la información y/o los documentos adjuntados, el CONCYTEC, podrá dar de baja el registro, sin perjuicio de iniciar las acciones, correspondientes.